Clinical Trial Update: ADenosine Vasodilator Independent Stenosis Evaluation II - ADVISE II

View source ↗

Summary

Completed update on the ADVISE II trial, evaluating a vasodilator-independent method for assessing coronary stenosis using adenosine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Adenosine (Adenosine)

Snippet

Sponsor: Volcano Corporation | Conditions: Cardiovascular Disease | Status: COMPLETED